ACD PHARMACEUTICALS AS: årsregnskap 2016 vs 2015
Grew 24% on revenue, stronger earnings, fresh owner capital
approved 2017-06-09; registry 2017-07-22; journal 2017 753674
Summary
What changed
Comparing Årsregnskap 2016 with 2015 for ACD PHARMACEUTICALS AS. Revenue 6.08m NOK → 7.56m NOK (+24.3%). Net result -598.3k NOK → -306.1k NOK. Equity 5.91m NOK → 6.71m NOK.
On the constructive side: revenue rose; net result improved; equity strengthened.
Also worth watching: payroll increased; cogs fell. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 6.08m NOK to 7.56m NOK (+24.3% YoY). Calculated
-
↑
Net result improved
Net result -598.3k NOK → -306.1k NOK (net margin -9.8% → -4.1%). Calculated
-
↑
Equity strengthened
Book equity 5.91m NOK → 6.71m NOK (equity ratio 53.9% → 65.1%). Calculated
-
↑
Cash rose
Bank deposits 127.7k NOK → 149.9k NOK (+17.3% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 2.54m NOK → 3.65m NOK (+1.11m NOK). Reported fact
Things to notice
-
·
Payroll increased
Salary cost 3.27m NOK → 3.60m NOK (54% → 48% of revenue). Calculated
-
·
COGS fell
COGS / varekostnad 211.8k NOK → 2 630 NOK (-98.8% YoY). Calculated